Bruce M. Jones, PharmD, BCPS, FIDSA
Clinical Pharmacy Specialist
Infectious Diseases/Antimicrobial Management Program
St. Joseph’s/Candler Health System, Inc.
Christopher M. Bland, PharmD, BCPS, FIDSA
Clinical Assistant Professor
Clinical and Administrative Pharmacy
University of Georgia College of Pharmacy
Learning Lounge Summary:
Up to 10% of patients self-report a penicillin allergy, of which the vast majority are inaccurate and not IgE-mediated. Penicillin skin testing provides a rapid means of implementing antimicrobial stewardship in a large number of patients. By providing penicillin skin testing to patients with a self-reported penicillin allergy, there is a potential to reduce the use of carbapenems, aztreonam, vancomycin, and other broad-spectrum agents. This results in cost savings and avoids the risk of increasing antimicrobial resistance from unnecessary overuse both in the short and long-term.